Showing results (1171-1180 of 1,572) with videos related to

Sort By:
Pageof 158
The Journal of Clinical Endocrinology and Metabolism|September 11, 2001
A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humansC Verdich, A Flint, J P Gutzwiller, et al.
The Journal of Biological Chemistry|June 16, 2011
Ligand modulation of the Epstein-Barr virus-induced seven-transmembrane receptor EBI2: identification of a potent and efficacious inverse agonistTau Benned-Jensen, Christopher Smethurst, Peter J Holst, et al.
Journal of Animal Science|March 26, 2014
Glucagon-like peptide 2 treatment may improve intestinal adaptation during weaningT Thymann, I Le Huërou-Luron, Y M Petersen, et al.
Diabetes, Obesity & Metabolism|October 4, 2016
The impact of EndoBarrier gastrointestinal liner in obese patients with normal glucose tolerance and in patients with type 2 diabetesUlrich Rohde, Cecilie A Federspiel, Peter Vilmann, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|November 25, 2025
GLP-1 Receptor Agonists for the Prevention of New-Onset Heart Failure: A Systematic Review and Meta-Analysis of Placebo-Controlled Randomized Clinical TrialsJoão Sérgio Neves, Carolina B Lobato, Ana Rita Leite, et al.
The Journal of Clinical Investigation|December 19, 2001
Tumorigenesis induced by the HHV8-encoded chemokine receptor requires ligand modulation of high constitutive activityP J Holst, M M Rosenkilde, D Manfra, et al.
Metabolism: Clinical and Experimental|April 15, 2011
Genetic variation within the TRPM5 locus associates with prediabetic phenotypes in subjects at increased risk for type 2 diabetesCaroline Ketterer, Karsten Müssig, Martin Heni, et al.
Pageof 158